Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Zoetis was the largest detractor during the quarter as the market continued to quickly penalize any disappointment in business momentum. The company remains...
— Buyside Damon Ficklin
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Zoetis Inc.
Zoetis ($ZTS) is a global leader in animal health, engaged in the discovery, development, and manufacture of veterinary pharmaceuticals, vaccines, and diagnostic products for livestock and companion animals. The manager divested...
Zoetis Inc. ($ZTS) is the global leader in animal health, producing specialized veterinary medicines, vaccines, and diagnostic tests for companion pets and livestock. Middle Coast initiated...
Zoetis Inc. is a dominant player in the animal health industry, but its capital allocation strategy has focused on share buybacks rather than organic growth. The com...